PLOTT RONALD TODD purchased 31.3% of their position (10K shares) of PHIO PHARMACEUTICALS CORP. on the open market
Open‑market purchase worth $10.3K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 9/30/2026ACC: 0001683168-26-007499
Director
Since Jul 2026
+10K
Net shares
Net buyer
$10.3K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
10K acquired
Non-Derivative Transactions2
Common Stock, $.0001 par value
Direct
Shares
+5K
Price / share
$1.03
Trade value
$5.15K
% of position
15.6%
9/28/2026
32K→37K
Common Stock, $.0001 par value
Direct
Shares
+5K
Price / share
$1.04
Trade value
$5.20K
% of position
13.5%
9/29/2026
37K→42K
Total
Net shares
+10K
Net value
$10.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.0001 par value Direct | 9/28/2026 | P · Purchase | +5K | $1.03 | $5.15K | 15.6% | 32K | 37K |
| Common Stock, $.0001 par value Direct | 9/29/2026 | P · Purchase | +5K | $1.04 | $5.20K | 13.5% | 37K | 42K |
| Total | +10K | $10.35K | ||||||
Derivative Transactions0
No derivative transactions reported